-
Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder
drugs
December 18, 2018
Buprenorphine-naloxone is cost-effective compared with extended-release naltrexone for treating opioid use disorder, according to a study published online Dec. 18 in the Annals of Internal Medicine.....
-
Early PT Linked to Less Opioid Use in Musculoskeletal Pain
drugs
December 17, 2018
For patients with musculoskeletal pain, early physical therapy is associated with reduced subsequent opioid use, according to a study published online Dec. 14 in JAMA Network Open......
-
FDA clears Pear/Sandoz app for opioid use disorder
pharmaphorum
December 13, 2018
A second mobile app developed by Pear Therapeutics to help opioid use disorder patients who have a more successful response to therapy has been given a green light by the FDA.
-
FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs
worldpharmanews
December 11, 2018
Today, the U.S. Food and Drug Administration (FDA) cleared a mobile medical application (app) to help increase retention (the amount of time a patient participates) in an outpatient treatment program for individuals with opioid use disorder (OUD).
-
Philadelphia looks to crack down on pharma reps with registration, gift banning
fiercepharma
December 05, 2018
It may soon be tougher to be a pharma sales rep in Philadelphia. Its city council will hold a public hearing Friday on a proposed bill (PDF) to regulate pharma manufacturer reps
-
Meth, Opioid Use in Pregnancy on the Rise
drugs
November 30, 2018
Methamphetamine and opioid use has soared among pregnant American women, putting the health of baby and mother at risk, a new study finds......
-
Kaleo under fire for price hikes on naloxone treatment
biopharmadive
November 22, 2018
A Senate report released Sunday heightened scrutiny of a pricing and prescribing strategy used by Kaleo to hike the price of its opioid overdose reversal autoinjector more than 600% in less than three years.
-
Keystone Folding Box Co. Introduces Opioid Rx Blister Pack
contractpharma
November 13, 2018
Keystone Folding Box Co. Introduces Opioid Rx Blister Pack
-
Opioid Use Often Persists in Workers' Compensation Claimants
drugs
November 01, 2018
Opioid Use Often Persists in Workers' Compensation Claimants
-
Nektar's back pain opioid gets approval for FDA review
biospectrumasia
October 11, 2018
NKTR-181, a long-acting (14-hour elimination half-life) mu-opioid receptor agonist, is the first analgesic opioid to show a low incidence of specific CNS-mediated side effects